News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Eye Disease Treatment Firm OccuLogix Inc. Files To Go Public
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Canada's OccuLogix Inc., whose products treat eye diseases, said on Friday it is planning to raise as much as $100 million in an initial public offering of common stock.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Deals
Boehringer Links with Irish Drug Delivery Start-Up Re-Vana in $1B+ Eye Deal
July 28, 2025
·
1 min read
·
Dan Samorodnitsky
Deals
GSK Bets Up To $12B for Multi-Program Cancer Pact With Hengrui
July 28, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
July 25, 2025
·
1 min read
·
Dan Samorodnitsky
I&I
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
July 24, 2025
·
2 min read
·
Dan Samorodnitsky
